Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription Articles published in J Clin Microbiol Retrieve available abstracts of 53 articles: HTML format

Single Articles

November 2021
1. ARMSTRONG DT, Tacheny EA, Olinger G, Howard R, et al
   SARS-CoV-2 Supply Shortages and Tuberculosis Diagnostics: Current Issues Requiring Immediate Solutions.
   J Clin Microbiol. 2021;59:e0077821.
   PubMed     Abstract available
   
   
   
2. WHITFIELD MG, Engelthaler DM, Allender C, Folkerts M, et al
   Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis.
   J Clin Microbiol. 2021 Nov 10:JCM0190721. doi: 10.1128/JCM.01907.
   PubMed     Abstract available
   
   
   September 2021
3. WIKELL A, Jonsson J, Dyrdak R, Henningsson AJ, et al
   The impact of borderline Quantiferon-Plus results for latent tuberculosis screening under routine conditions in a low endemic setting.
   J Clin Microbiol. 2021 Sep 22:JCM0137021. doi: 10.1128/JCM.01370.
   PubMed     Abstract available
   
   
   
4. SHIER KL
   Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.
   J Clin Microbiol. 2021;59:e0141421.
   PubMed     Abstract available
   
   
   
5. WARD JD, Cornaby C, Schmitz JL
   Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.
   J Clin Microbiol. 2021;59:e0081121.
   PubMed     Abstract available
   
   
   
6. MINNIES S, Reeve BWP, Rockman L, Nyawo G, et al
   Xpert MTB/RIF Ultra is highly sensitive for the diagnosis of tuberculosis lymphadenitis in an HIV-endemic setting.
   J Clin Microbiol. 2021 Sep 1:JCM0131621. doi: 10.1128/JCM.01316.
   PubMed     Abstract available
   
   
   July 2021
7. TESFAYE F, Walles J, Sturegard E, Winqvist N, et al
   Longitudinal Mycobacterium tuberculosis specific interferon-gamma responses in Ethiopian HIV-negative women during pregnancy and post-partum.
   J Clin Microbiol. 2021 Jul 28:JCM0086821. doi: 10.1128/JCM.00868.
   PubMed     Abstract available
   
   
   
8. MACLEAN E, Nathavitharana RR
   Progress toward Developing Sensitive Non-Sputum-Based Tuberculosis Diagnostic Tests: the Promise of Urine Cell-Free DNA.
   J Clin Microbiol. 2021;59:e0070621.
   PubMed     Abstract available
   
   
   June 2021
9. DIPPENAAR A, Goossens SN, Grobbelaar M, Oostvogels S, et al
   Nanopore sequencing for Mycobacterium tuberculosis: a critical review of the literature, new developments and future opportunities.
   J Clin Microbiol. 2021 Jun 16:JCM0064621. doi: 10.1128/JCM.00646.
   PubMed     Abstract available
   
   
   
10. FERNANDEZ-HUERTA M, Moreto C, Vila-Olmo N, Garcia de Cara EI, et al
    Evaluation of the Fully-Automated Chemiluminescence Analyzer LIAISON XL for the Performance of the QuantiFERON-TB Gold Plus Assay in a Low-Incidence Tuberculosis Area.
    J Clin Microbiol. 2021 Jun 2:JCM0060321. doi: 10.1128/JCM.00603.
    PubMed     Abstract available
    
    
    
11. DE HAAS P, Yenew B, Mengesha E, Slyzkyi A, et al
    The Simple One-Step (SOS) stool processing method for use with the Xpert MTB/RIF assay for a child-friendly diagnosis of tuberculosis closer to the point-of-care.
    J Clin Microbiol. 2021 Jun 2:JCM0040621. doi: 10.1128/JCM.00406.
    PubMed     Abstract available
    
    
    April 2021
12. FENG PJ, Wu Y, Ho CS, Chinna L, et al
    Impact of T-Cell Xtend on T-SPOT.TB Assay in High-Risk Individuals after Delayed Blood Sample Processing.
    J Clin Microbiol. 2021;59.
    PubMed     Abstract available
    
    
    
13. NADARAJAN D, Hillemann D, Kamara R, Foray L, et al
    Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone.
    J Clin Microbiol. 2021;59.
    PubMed     Abstract available
    
    
    March 2021
14. BOGAERTS B, Delcourt T, Soetaert K, Boarbi S, et al
    A bioinformatics WGS workflow for clinical Mycobacterium tuberculosis complex isolate analysis, validated using a reference collection extensively characterized with conventional methods and in silico approaches.
    J Clin Microbiol. 2021 Mar 31. pii: JCM.00202-21. doi: 10.1128/JCM.00202.
    PubMed     Abstract available
    
    
    
15. ORESKOVIC A, Panpradist N, Marangu D, Ngwane MW, et al
    Diagnosing pulmonary tuberculosis using sequence-specific purification of urine cell-free DNA.
    J Clin Microbiol. 2021 Mar 31. pii: JCM.00074-21. doi: 10.1128/JCM.00074.
    PubMed     Abstract available
    
    
    February 2021
16. SODERSTEN E, Ongarello S, Mantsoki A, Wyss R, et al
    Diagnostic Accuracy Study of a Novel Blood-Based Assay for Identification of Tuberculosis in People Living with HIV.
    J Clin Microbiol. 2021;59.
    PubMed     Abstract available
    
    
    
17. KOSER CU, Georghiou SB, Schon T, Salfinger M, et al
    On the consequences of poorly defined breakpoints for rifampin susceptibility testing of Mycobacterium tuberculosis complex.
    J Clin Microbiol. 2021 Feb 10. pii: JCM.02328-20. doi: 10.1128/JCM.02328.
    PubMed     Abstract available
    
    
    
18. MBELELE PM, Mpolya EA, Sauli E, Mtafya B, et al
    Mycobactericidal effect of different regimens measured by molecular bacterial load assay among people treated for multidrug-resistant tuberculosis in Tanzania.
    J Clin Microbiol. 2021 Feb 3. pii: JCM.02927-20. doi: 10.1128/JCM.02927.
    PubMed     Abstract available
    
    
    December 2020
19. CAO Y, Parmar H, Gaur RL, Lieu D, et al
    Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second-line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum.
    J Clin Microbiol. 2020 Dec 9. pii: JCM.02314-20. doi: 10.1128/JCM.02314.
    PubMed     Abstract available
    
    
    
20. DE VOS M, Scott L, David A, Trollip A, et al
    Comparative analytical evaluation of four centralized platforms for the detection of M. tuberculosis complex and resistance to rifampicin and isoniazid.
    J Clin Microbiol. 2020 Dec 2. pii: JCM.02168-20. doi: 10.1128/JCM.02168.
    PubMed     Abstract available
    
    
    November 2020
21. LORENTE-LEAL V, Liandris E, Pacciarini M, Botelho A, et al
    Direct PCR on tissue samples to detect Mycobacterium tuberculosis complex: an alternative to the bacteriological culture.
    J Clin Microbiol. 2020 Nov 25. pii: JCM.01404-20. doi: 10.1128/JCM.01404.
    PubMed     Abstract available
    
    
    
22. HE Y, Lyon CJ, Nguyen DT, Liu C, et al
    Serum-based Diagnosis of Pediatric Tuberculosis by Assay of Mycobacterium tuberculosis Factors: a retrospective cohort study.
    J Clin Microbiol. 2020 Nov 25. pii: JCM.01756-20. doi: 10.1128/JCM.01756.
    PubMed     Abstract available
    
    
    
23. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Unstimulated pleural fluid interferon-gamma for diagnosis of tuberculous pleural effusion: a systematic review and meta-analysis.
    J Clin Microbiol. 2020 Nov 18. pii: JCM.02112-20. doi: 10.1128/JCM.02112.
    PubMed     Abstract available
    
    
    
24. LIU HC, Gao YL, Li DF, Zhao XY, et al
    Value of Xpert MTB/RIF Using Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis.
    J Clin Microbiol. 2020 Nov 11. pii: JCM.02170-20. doi: 10.1128/JCM.02170.
    PubMed     Abstract available
    
    
    October 2020
25. MEYER AJ, Ochom E, Turimumahoro P, Byanyima P, et al
    C-Reactive Protein for Active Tuberculosis Among Inpatients without HIV in Uganda: A Diagnostic Accuracy Study.
    J Clin Microbiol. 2020 Oct 21. pii: JCM.02162-20. doi: 10.1128/JCM.02162.
    PubMed     Abstract available
    
    
    
26. MANYELO CM, Solomons RS, Walzl G, Chegou NN, et al
    Tuberculous meningitis: pathogenesis, immune responses, diagnostic challenges, and the potential of biomarker-based approaches.
    J Clin Microbiol. 2020 Oct 21. pii: JCM.01771-20. doi: 10.1128/JCM.01771.
    PubMed     Abstract available
    
    
    
27. SMITH C, Halse TA, Shea J, Modestil H, et al
    Assessing Nanopore sequencing for clinical diagnostics: A comparison of NGS methods for Mycobacterium tuberculosis.
    J Clin Microbiol. 2020 Oct 14. pii: JCM.00583-20. doi: 10.1128/JCM.00583.
    PubMed     Abstract available
    
    
    September 2020
28. SHEA J, Halse TA, Kohlerschmidt D, Lapierre P, et al
    Low-level rifampin resistance and rpoB mutations in Mycobacterium tuberculosis: An analysis of whole-genome sequencing and drug susceptibility test data in New York.
    J Clin Microbiol. 2020 Sep 30. pii: JCM.01885-20. doi: 10.1128/JCM.01885.
    PubMed     Abstract available
    
    
    
29. BATTAGLIA S, Spitaleri A, Cabibbe AM, Meehan CJ, et al
    Characterization of genomic variants associated with resistance to bedaquiline and delamanid in naive Mycobacterium tuberculosis clinical strains.
    J Clin Microbiol. 2020 Sep 9. pii: JCM.01304-20. doi: 10.1128/JCM.01304.
    PubMed     Abstract available
    
    
    August 2020
30. CATANZARO DG, Colman RE, Linger Y, Georghiou SB, et al
    Laboratory evaluation of a lateral-flow cell for molecular detection of first-line and second-line anti-tuberculosis drug resistance.
    J Clin Microbiol. 2020 Aug 19. pii: JCM.01417-20. doi: 10.1128/JCM.01417.
    PubMed     Abstract available
    
    
    
31. MACLEAN E, Kohli M, Weber SF, Suresh A, et al
    Advances in Molecular Diagnosis of Tuberculosis.
    J Clin Microbiol. 2020 Aug 5. pii: JCM.01582-19. doi: 10.1128/JCM.01582.
    PubMed     Abstract available
    
    
    July 2020
32. ESMAIL A, Pooran A, Sabur NF, Fadul M, et al
    An optimal diagnostic strategy for tuberculosis in hospitalized HIV-Infected patients using Xpert and LAM.
    J Clin Microbiol. 2020 Jul 29. pii: JCM.01032-20. doi: 10.1128/JCM.01032.
    PubMed     Abstract available
    
    
    
33. CABIBBE AM, Spitaleri A, Battaglia S, Colman RE, et al
    Application of targeted Next Generation Sequencing assay on a portable sequencing platform for culture-free detection of drug resistant tuberculosis from clinical samples.
    J Clin Microbiol. 2020 Jul 29. pii: JCM.00632-20. doi: 10.1128/JCM.00632.
    PubMed     Abstract available
    
    
    
34. BLAUENFELDT T, Villar-Hernandez R, Garcia-Garcia E, Latorre I, et al
    Diagnostic accuracy of IP-10 mRNA release assay for tuberculosis.
    J Clin Microbiol. 2020 Jul 22. pii: JCM.00848-20. doi: 10.1128/JCM.00848.
    PubMed     Abstract available
    
    
    June 2020
35. SUN L, Zhu Y, Fang M, Shi Y, et al
    Evaluation of Xpert MTB/RIF Ultra assay for the diagnosis of childhood tuberculosis: a multicenter accuracy study.
    J Clin Microbiol. 2020 Jun 10. pii: JCM.00702-20. doi: 10.1128/JCM.00702.
    PubMed     Abstract available
    
    
    
36. SSENGOOBA W, de Dieu Iragena J, Nakiyingi L, Mujumbi S, et al
    Accuracy of Xpert Ultra in the diagnosis of pulmonary tuberculosis among children in Uganda: a sub-study from the SHINE trial.
    J Clin Microbiol. 2020 Jun 3. pii: JCM.00410-20. doi: 10.1128/JCM.00410.
    PubMed     Abstract available
    
    
    April 2020
37. HU X, Liao S, Bai H, Gupta S, et al
    LncRNA and predictive model to improve the diagnosis of clinically diagnosed pulmonary tuberculosis.
    J Clin Microbiol. 2020 Apr 15. pii: JCM.01973-19. doi: 10.1128/JCM.01973.
    PubMed     Abstract available
    
    
    
38. MEHAFFY C, Kruh-Garcia NA, Graham B, Jarlsberg LG, et al
    Identification of Mycobacterium tuberculosis peptides in serum extracellular vesicles from persons with latent tuberculosis infection.
    J Clin Microbiol. 2020 Apr 3. pii: JCM.00393-20. doi: 10.1128/JCM.00393.
    PubMed     Abstract available
    
    
    March 2020
39. BUONSENSO D, Delogu G, Perricone C, Grossi R, et al
    Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children.
    J Clin Microbiol. 2020 Mar 30. pii: JCM.00272-20. doi: 10.1128/JCM.00272.
    PubMed     Abstract available
    
    
    February 2020
40. BUDVYTIENE I, Banaei N
    Simple Processing of Formalin-Fixed Paraffin-Embedded Tissue for Accurate Testing with the Xpert MTB/RIF Assay.
    J Clin Microbiol. 2020;58.
    PubMed    
    
    
    
41. DE MAERTELAERE E, Vandendriessche S, Verhasselt B, Coorevits L, et al
    Evaluation of QuantiFERON-TB(R) Gold Plus on LIAISON(R) XL in a low tuberculosis incidence setting.
    J Clin Microbiol. 2020 Feb 5. pii: JCM.00159-20. doi: 10.1128/JCM.00159.
    PubMed     Abstract available
    
    
    
42. FRANCO SOTOMAYOR G, Rivera-Olivero IA, Leon-Benitez M, Uruchima-Campoverde SE, et al
    Fast, simple and cheap: the Kudoh-Ogawa swab method as an alternative to the Petroff-Lowenstein Jensen method for the culturing of Mycobacterium tuberculosis.
    J Clin Microbiol. 2020 Feb 5. pii: JCM.01424-19. doi: 10.1128/JCM.01424.
    PubMed     Abstract available
    
    
    January 2020
43. XIAO G, He X, Zhang S, Liu Y, et al
    Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major Mycobacterium Species.
    J Clin Microbiol. 2020;58.
    PubMed     Abstract available
    
    
    
44. WON D, Park JY, Kim HS, Park Y, et al
    Comparative results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus assays for tuberculosis diagnosis of clinical samples.
    J Clin Microbiol. 2020 Jan 22. pii: JCM.01854-19. doi: 10.1128/JCM.01854.
    PubMed     Abstract available
    
    
    
45. O'CONNOR JA, Corcoran GD, O'Reilly B, O'Mahony J, et al
    MALDI-tof MS for the investigation of Mycobacterium tuberculosis complex outbreaks: a type dream?
    J Clin Microbiol. 2020 Jan 15. pii: JCM.02077-19. doi: 10.1128/JCM.02077.
    PubMed     Abstract available
    
    
    October 2019
46. WEINRICK B
    Genotyping of Mycobacterium tuberculosis Rifampin Resistance Associated Mutations Using Data From Xpert(R) MTB/RIF Ultra Enables Large-Scale Tuberculosis Molecular Epidemiology Studies.
    J Clin Microbiol. 2019 Oct 23. pii: JCM.01504-19. doi: 10.1128/JCM.01504.
    PubMed     Abstract available
    
    
    
47. LISBOA VDC, Ribeiro-Alves M, Correa RDS, Lopes IR, et al
    The predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis Among Other Exudative Etiologies.
    J Clin Microbiol. 2019 Oct 16. pii: JCM.00927-19. doi: 10.1128/JCM.00927.
    PubMed     Abstract available
    
    
    June 2019
48. SIDDIQI OK, Birbeck GL, Ghebremichael M, Mubanga E, et al
    A Prospective Cohort Study on the Performance of CSF Xpert MTB/RIF, CSF and Urine LAM Lateral Flow Assay for the Diagnosis of Tuberculous Meningitis in Zambia.
    J Clin Microbiol. 2019 Jun 12. pii: JCM.00652-19. doi: 10.1128/JCM.00652.
    PubMed     Abstract available
    
    
    April 2019
49. PORMOHAMMAD A, Nasiri MJ, McHugh TD, Riahi SM, et al
    A systematic review and meta-analysis of the diagnostic accuracy of nucleic acid amplification tests in cerebrospinal fluid for tuberculous meningitis.
    J Clin Microbiol. 2019 Apr 3. pii: JCM.01113-18. doi: 10.1128/JCM.01113.
    PubMed     Abstract available
    
    
    February 2019
50. PARK JH, Jin CE, Koo B, Kwon J, et al
    A simple microfluidic assay for diagnosing tuberculous meningitis in HIV-uninfected patients.
    J Clin Microbiol. 2019 Feb 27. pii: JCM.01975-18. doi: 10.1128/JCM.01975.
    PubMed     Abstract available
    
    
    January 2019
51. HU P, Zhang H, Fleming J, Zhu G, et al
    Retrospective analysis of false-positive and disputed rifampin resistance Xpert MTB/RIF assay results in clinical samples from a referral hospital in Hunan, China.
    J Clin Microbiol. 2019 Jan 23. pii: JCM.01707-18. doi: 10.1128/JCM.01707.
    PubMed     Abstract available
    
    
    
52. HOGAN CA, Tien S, Pai M, Banaei N, et al
    Higher Positivity Rate with Fourth-Generation QuantiFERON-TB Gold Plus Assay in Low-Risk U.S. Health Care Workers.
    J Clin Microbiol. 2019;57.
    PubMed    
    
    
    
53. XU Y, Liang B, Du C, Tian X, et al
    Rapid Identification of Clinically Relevant Mycobacterium Species by Multicolor Melting Curve Analysis.
    J Clin Microbiol. 2019;57.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: